FDA Inspection 1281522 — Roberto Giugliani, MD, PhD
The FDA completed an inspection of Roberto Giugliani, MD, PhD on Sep 2, 2025 in Porto Alegre. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 2, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Porto Alegre (Brazil)
Additional Details
Clinical Investigator (CI)